Artemether
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C16H26O5 298.37
3,12-Epoxy-12H-pyrano [4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3R,5aS, 6R,8aS, 9R, 10S,12R, 12aR);
(3R,5S,6R,8aS,9R, 10S, 12R, 12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano [4,3-j]-1,2-benzodioxepin CAS RN®: 71963-77-4; UNII: C7D6T3H22J.
1 DEFINITION
Artemether contains NLT 98.0% and NMT 102.0% of artemether (C16H2605).
2 IDENTIFICATION
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
Protect all solutions containing artemether from light.
Solution A: Acetonitrile and water (200:800)
Solution B: Acetonitrile and water (800:200)
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 2 | 100 | 0 |
| 3 | 40 | 60 |
| 14 | 0 | 100 |
| 15.5 | 0 | 100 |
| 15.6 | 100 | 0 |
| 18 | 100 | 0 |
Diluent: Acetonitrile and water (50:50)
Standard solution: 0.5 mg/mL of USP Artemether RS in Diluent. Sonicate to dissolve if necessary.
Sample solution: 0.5 mg/mL of Artemether in Diluent. Sonicate to dissolve if necessary.
Chromatographic system
(See Chromatography (621), System Suitability.)
Detector: UV 210 nm
Column: 4.6-mm × 15-cm; 1.8-µm packing L1
Temperatures
Autosampler: 5°
Column: 30°
Flow rate: 0.8 mL/min
Injection volume: 50 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of artemether (C16H26O5) in the portion of Artemether taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of artemether from the Sample solution
rS = peak response of artemether from the Standard solution
CS = concentration of USP Artemether RS in the Standard solution (mg/mL)
CU = concentration of Artemether in the Sample solution (mg/mL)
Acceptance criteria: 98.0%-102.0%
4 IMPURITIES
4.1 RESIDUE ON IGNITION (281)
NMT 0.1%
4.2 ORGANIC IMPURITIES
Protect all solutions containing artemether from light.
Solution A, Solution B, Mobile phase, Diluent, and Chromatographic system: Proceed as directed in the Assay.
Sensitivity solution: 5 µg/mL of USP Artemether RS in Diluent. Sonicate to dissolve if necessary.
Standard solution: 0.02 mg/mL of USP Artemether RS in Diluent. Sonicate to dissolve if necessary.
Sample solution: 10 mg/mL of Artemether in Diluent. Sonicate to dissolve if necessary.
System suitability
Samples: Sensitivity solution and Standard solution
Suitability requirements
Relative standard deviation: NMT 5%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Artemether taken:
Result = (rU/rS) x (CS/CU) × (1/F) x 100
rU = peak response of each impurity from the Sample solution
rS = peak response of artemether from the Standard solution
CS = concentration of USP Artemether RS in the Standard solution (mg/mL)
CU = concentration of Artemether in the Sample solution (mg/mL)
F = relative response factor (see Table 2)
Acceptance criteria: See Table 2. The reporting threshold is 0.05%.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
Cyclohexanone propanal derivative isomer 1a,b | 0.50 | 5 | 0.2 |
Cyclohexanone propanal derivative isomer 2a,b | 0.53 | 5 | |
| Dihydroartemisinin (artenimol)c | 0.55 | 1.0 | 0.2 |
| Artimisitened | 0.65 | 35.7 | 0.10 |
| Furoisochromen derivativee | 0.78 | 0.36 | 0.2 |
| Artemether related compound B (α-artemether)f | 0.86 | 1.0 | 0.2 |
| Artemether | 1.0 | - | - |
| Any individual unspecied impurity | - | 1.0 | 0.10 |
| Total impurities | - | - | 1.0 |
a 2-(4-Methyl-2-oxo-3-(3-oxobutyl) cyclohexyl)propanal.
b The chromatographic system resolves two isomers. The sum of the values is reported.
c (3R,5S,6R,8aS,9R,12R,12aR)-3,6,9-Trimethyldecahydro-3,12-epoxy [1,2]dioxepino [4,3-i]isochromen-10-ol.
d (3R,5S,6R,8aS, 125, 12aR)-Octahydro-3,6-dimethyl-9-methylene-3,12-epoxy-12H-pyrano [4,3-j]-1,2-benzodioxepin-10(3H)-one.
e (3aS,4R,6aS,7R,8S, 10R, 10aS)-8-Methoxy-4,7-dimethyldecahydrofuro[3,2-i]isochromen-10-yl acetate.
f (3R,5aS,6R,8aS,9R, 10R, 12R, 12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano [4,3-j]-1,2-benzodioxepin.
5 SPECIFIC TESTS
OPTICAL ROTATION TATION (781S), Procedures, Specific Rotation
Sample solution: 10 mg/mL in dehydrated alcohol
Acceptance criteria: +166° to +173° measured at 20°
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed, light-resistant containers. Store in a refrigerator.
USP REFERENCE STANDARDS (11).
USP Artemether RSA (USP 1-May-2023)

